June 24, 2024
Image default
Politics

U.S. delays decision on COVID vaccine for children under 5 by at least 2 months

Published by
Reuters

By Ankur Banerjee and Michael Erman (Reuters) – A U.S. decision on Pfizer and BioNTech’s COVID-19 vaccine for children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration said it needed more data. The FDA had planned to make a decision on the vaccine based on early trial data because of what it had called a great public health need due to the surge in infections caused by the Omicron variant of the coronavirus. The decision was slated for next week with a rollout starting as soon as Feb. 21. On Friday, the agency said it had reviewe…

Read More

Related posts

GOP Rep. Meijer receiving threats after ‘vote of conscience’ to impeach Trump

The_Proponent

U.S. Senate to vote Tuesday on raising government’s debt limit

The_Proponent

Queen Elizabeth II, Longest Reigning Monarch Of Britain, Dies Aged 96

The_Proponent

Senate panel opens hearing on historic U.S. Supreme Court pick Jackson

The_Proponent

Kansas abortion vote rocks US midterms outlook

The_Proponent

Martin Luther King’s family joins call for US voting reform

The_Proponent

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.